Skip to main content
. 2023 Jun 20;15(6):1779. doi: 10.3390/pharmaceutics15061779

Scheme 16.

Scheme 16

Reagents and conditions: (i) TBDMSCl (3 eq.), imidazole (5.0 eq.), THF; (ii) TBAF (1 eq.), THF, 0 °C; (iii) trifuoromethanesulfonic anhydride (1.2 eq.), 2,6-dimethylpyridine (1 eq.), DCM, 0 °C.